全文获取类型
收费全文 | 2374篇 |
免费 | 152篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 143篇 |
妇产科学 | 38篇 |
基础医学 | 314篇 |
口腔科学 | 77篇 |
临床医学 | 191篇 |
内科学 | 494篇 |
皮肤病学 | 58篇 |
神经病学 | 411篇 |
特种医学 | 202篇 |
外国民族医学 | 20篇 |
外科学 | 200篇 |
综合类 | 44篇 |
预防医学 | 102篇 |
眼科学 | 19篇 |
药学 | 80篇 |
中国医学 | 3篇 |
肿瘤学 | 133篇 |
出版年
2021年 | 30篇 |
2020年 | 19篇 |
2019年 | 36篇 |
2018年 | 40篇 |
2017年 | 34篇 |
2016年 | 36篇 |
2015年 | 47篇 |
2014年 | 61篇 |
2013年 | 93篇 |
2012年 | 72篇 |
2011年 | 74篇 |
2010年 | 81篇 |
2009年 | 78篇 |
2008年 | 91篇 |
2007年 | 90篇 |
2006年 | 89篇 |
2005年 | 88篇 |
2004年 | 69篇 |
2003年 | 60篇 |
2002年 | 62篇 |
2001年 | 53篇 |
2000年 | 51篇 |
1999年 | 70篇 |
1998年 | 71篇 |
1997年 | 52篇 |
1996年 | 45篇 |
1995年 | 39篇 |
1994年 | 46篇 |
1993年 | 45篇 |
1992年 | 61篇 |
1991年 | 56篇 |
1990年 | 47篇 |
1989年 | 67篇 |
1988年 | 56篇 |
1987年 | 57篇 |
1986年 | 50篇 |
1985年 | 37篇 |
1984年 | 32篇 |
1983年 | 36篇 |
1982年 | 26篇 |
1981年 | 17篇 |
1980年 | 23篇 |
1979年 | 19篇 |
1977年 | 30篇 |
1976年 | 18篇 |
1975年 | 21篇 |
1974年 | 22篇 |
1971年 | 17篇 |
1970年 | 18篇 |
1968年 | 16篇 |
排序方式: 共有2541条查询结果,搜索用时 0 毫秒
61.
62.
63.
O Meyer J C Piette P Bourgeois P Fallas O Blétry P Jungers M F Kahn P Godeau A Ryckewaert 《Annales de médecine interne》1987,138(4):256-262
Twenty-five patients with at least 3 of 1982 ARA criteria of SLE but without the ANA, were compared with 91 patients with 4 or more of the ARA criteria of lupus with positive ANA. The ANA-negative group was characterised by the low incidence of skin involvement, serous effusions and alopecia, and a relatively high incidence of thrombocytopaenia and venous and arterial thrombosis. Three types of antiphospholipid antibodies were looked for: the VDRL, antiprothrombinase and anticardiolipin antibodies by an immuno-enzymatic method. The VDRL was the only antibody which was significantly commoner in the ANA-negative group. Statistical studies showed that the three methods of demonstrating antiphospholipid antibodies detected crossed but not identical specificities. In the ANA-positive group only the antiprothrombinase was associated with a high incidence of venous thrombosis and stroke. In the ANA-negative group, only the anticardiolipin antibodies were associated with a high incidence of arterial or venous thrombosis. Two subgroups may be identified in the group of ANA-negative lupus patients: firstly, those with high anticardiolipin antibody titres with a high incidence of thrombotic and haematological complications, and, secondly, patients with low anticardiolipin antibody levels with a high incidence of cutaneous involvement, serous effusions and Raynaud's phenomenon. 相似文献
64.
65.
66.
67.
68.
Sany J Bourgeois P Saraux A Durieux S Lafuma A Daurès JP Guillemin F Sibilia J 《Annals of the rheumatic diseases》2004,63(10):1235-1240
OBJECTIVE: To describe the characteristics of rheumatoid arthritis in patients managed by hospital based rheumatologists in France. METHODS: All public and non-profit private hospitals in France were invited to participate in a cross sectional study. Clinical data on the day of inclusion and health resources used for rheumatoid arthritis over the previous 12 months (treatments, medical devices, physician visits, examinations, hospital admissions, and other health professional care) were recorded. RESULTS: 1109 patients from 75 centres located throughout the country were included (846 female; mean disease duration, 10.6 years; mean age, 56.7 years). Active disease (swollen joint count > or =6, tender joint count > or =6, and two of: morning stiffness > or =45 min, C reactive protein > or =20 mg/l, erythrocyte sedimentation rate >28 mm/h) was observed in 146 patients (13.2%). Mean (SD) DAS(28) was 4.51 (1.55). Severe extra-articular manifestations were reported in 8.4%. ACR functional status was: class I, 19%; class II, 28%; class III, 31%; class IV, 22%. Comorbidity was observed in 44.9% of cases, particularly chronic pulmonary disease and coronary or peripheral vascular disease. Average AIMS2-SF dimension scores were between 4.56 and 6.18, and mean HAQ was 1.32 (0.77). Disease modifying antirheumatic drugs (DMARDs) were prescribed for 82.1% of the patients. During the previous four weeks, one DMARD was used in 62.5%, and two or more in 19.5%. Corticosteroids were prescribed in 72%. CONCLUSIONS: In a rheumatoid arthritis population managed by hospital based rheumatologists, the disease was active in 13% and severe in more than one third of cases. 相似文献
69.
Rashid Khan Ashwani K Singal Bhupinderjit S Anand 《World journal of gastroenterology : WJG》2014,20(34):11935-11938
Alcohol abuse and chronic hepatitis C virus(HCV)infection are two major causes of chronic liver disease in the United States.About 10%-15%of liver transplants performed in the United States are for patients with cirrhosis due to combined alcohol and HCV infection.Data on outcomes on graft and patient survival,HCV recurrence,and relapse of alcohol use comparing transplants in hepatitis C positive drinkers compared to alcohol abuse or hepatitis C alone are conflicting in the literature.Some studies report a slightly better overall outcome in patients who were transplanted for alcoholic cirrhosis vs those transplanted for HCV alone or for combined HCV and alcohol related cirrhosis.However,some other studies do not support these observations.However,most studies are limited to a retrospective design or small sample size.Larger prospective multicenter studies are needed to better define the outcomes in hepatitis C drinkers. 相似文献
70.
Hermine A van Duyvenvoorde Julian C Lui Sarina G Kant Wilma Oostdijk Antoinet CJ Gijsbers Mari?tte JV Hoffer Marcel Karperien Marie JE Walenkamp Cees Noordam Paul G Voorhoeve Verónica Mericq Alberto M Pereira Hedi L Claahsen-van de Grinten Sandy A van Gool Martijn H Breuning Monique Losekoot Jeffrey Baron Claudia AL Ruivenkamp Jan M Wit 《European journal of human genetics : EJHG》2014,22(5):602-609
Height is a highly heritable and classic polygenic trait. Recent genome-wide association studies (GWAS) have revealed that at least 180 genetic variants influence adult height. However, these variants explain only about 10% of the phenotypic variation in height. Genetic analysis of short individuals can lead to the discovery of novel rare gene defects with a large effect on growth. In an effort to identify novel genes associated with short stature, genome-wide analysis for copy number variants (CNVs), using single-nucleotide polymorphism arrays, in 162 patients (149 families) with short stature was performed. Segregation analysis was performed if possible, and genes in CNVs were compared with information from GWAS, gene expression in rodents'' growth plates and published information. CNVs were detected in 40 families. In six families, a known cause of short stature was found (SHOX deletion or duplication, IGF1R deletion), in two combined with a de novo potentially pathogenic CNV. Thirty-three families had one or more potentially pathogenic CNVs (n=40). In 24 of these families, segregation analysis could be performed, identifying three de novo CNVs and nine CNVs segregating with short stature. Four were located near loci associated with height in GWAS (ADAMTS17, TULP4, PRKG2/BMP3 and PAPPA). Besides six CNVs known to be causative for short stature, 40 CNVs with possible pathogenicity were identified. Segregation studies and bioinformatics analysis suggested various potential candidate genes. 相似文献